- Home
- RVSB vs CNTB Comparison
RVSB vs CNTB Comparison
Compare RVSB & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- CNTB
- Stock Information
- Founded
- RVSB 1923
- CNTB 2012
- Country
- RVSB United States
- CNTB United States
- Employees
- RVSB N/A
- CNTB N/A
- Industry
- RVSB Savings Institutions
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- RVSB Finance
- CNTB Health Care
- Exchange
- RVSB Nasdaq
- CNTB Nasdaq
- Market Cap
- RVSB 99.6M
- CNTB 68.5M
- IPO Year
- RVSB 1993
- CNTB 2021
- Fundamental
- Price
- RVSB $4.74
- CNTB $1.17
- Analyst Decision
- RVSB
- CNTB Strong Buy
- Analyst Count
- RVSB 0
- CNTB 1
- Target Price
- RVSB N/A
- CNTB $8.00
- AVG Volume (30 Days)
- RVSB 17.9K
- CNTB 24.6K
- Earning Date
- RVSB 10-24-2024
- CNTB 09-05-2024
- Dividend Yield
- RVSB 1.70%
- CNTB N/A
- EPS Growth
- RVSB N/A
- CNTB N/A
- EPS
- RVSB 0.05
- CNTB N/A
- Revenue
- RVSB $46,297,000.00
- CNTB $24,116,000.00
- Revenue This Year
- RVSB N/A
- CNTB N/A
- Revenue Next Year
- RVSB $12.93
- CNTB $63.90
- P/E Ratio
- RVSB $98.52
- CNTB N/A
- Revenue Growth
- RVSB N/A
- CNTB N/A
- 52 Week Low
- RVSB $3.30
- CNTB $0.68
- 52 Week High
- RVSB $6.57
- CNTB $2.84
- Technical
- Relative Strength Index (RSI)
- RVSB 51.94
- CNTB 44.02
- Support Level
- RVSB $4.45
- CNTB $1.18
- Resistance Level
- RVSB $4.72
- CNTB $1.26
- Average True Range (ATR)
- RVSB 0.12
- CNTB 0.07
- MACD
- RVSB -0.00
- CNTB -0.01
- Stochastic Oscillator
- RVSB 61.43
- CNTB 13.59
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.